Twist Stock Performance


USD 37.79  3.19  9.22%   

Twist Bioscience has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 2.275, which indicates a somewhat significant risk relative to the market. Let's try to break down what Twist's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Twist Bioscience will likely underperform. Although it is important to respect Twist Bioscience Corp current price movements, it is better to be realistic regarding the information on the equity's historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By inspecting Twist Bioscience Corp technical indicators, you can presently evaluate if the expected return of 0.19% will be sustainable into the future. Twist Bioscience Corp right now has a risk of 5.67%. Please validate Twist Bioscience maximum drawdown, as well as the relationship between the skewness and day typical price to decide if Twist Bioscience will be following its existing price patterns.
Twist Performance
2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Twist Bioscience Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Twist Bioscience may actually be approaching a critical reversion point that can send shares even higher in October 2022. ...more

Twist Price Channel

Quick Ratio7.19
Fifty Two Week Low25.07
Target High Price70.00
Fifty Two Week High139.99
Target Low Price33.00

Twist Bioscience Relative Risk vs. Return Landscape

If you would invest  3,708  in Twist Bioscience Corp on July 1, 2022 and sell it today you would earn a total of  71.00  from holding Twist Bioscience Corp or generate 1.91% return on investment over 90 days. Twist Bioscience Corp is currently generating 0.1895% in daily expected returns and assumes 5.6673% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Twist, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Twist Bioscience is expected to generate 4.96 times more return on investment than the market. However, the company is 4.96 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The DOW is currently generating roughly -0.09 per unit of risk.

Twist Bioscience Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Twist Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Twist Bioscience Corp, and traders can use it to determine the average amount a Twist Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0334

Good Returns
Average Returns
Small ReturnsTWST
Negative Returns
Estimated Market Risk
  actual daily
 49 %
of total potential
Expected Return
  actual daily
 3 %
of total potential
Risk-Adjusted Return
  actual daily
 2 %
of total potential
Based on monthly moving average Twist Bioscience is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Twist Bioscience by adding it to a well-diversified portfolio.

About Twist Bioscience Performance

To evaluate Twist Bioscience Corp Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Twist Bioscience generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Twist Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Twist Bioscience Corp market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Twist's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 652 people.

Things to note about Twist Bioscience Corp

Checking the ongoing alerts about Twist Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Twist Bioscience Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Twist Bioscience Alerts

Equity Alerts and Improvement Suggestions

Twist Bioscience has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 163.11 M. Net Loss for the year was (187.51 M) with profit before overhead, payroll, taxes, and interest of 51.71 M.
Twist Bioscience Corp currently holds about 573.86 M in cash with (151.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.2.
Latest headline from MacroaxisInsider: Exercise or conversion by Paula Green of 8514 shares of Twist Bioscience subject to Rule 16b-3
Additionally, take a look at World Market Map. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for analysis

When running Twist Bioscience Corp price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine Twist Bioscience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.